Clifford Saffron
Amministratore Delegato presso OPTIMUS HEALTHCARE SERVICES, INC.
Posizioni attive di Clifford Saffron
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OPTIMUS HEALTHCARE SERVICES, INC. | Amministratore Delegato | 27/07/2023 | - |
| Direttore operativo | 10/07/2023 | - | |
| Consigliere Generale | 01/04/2021 | - | |
| Presidente | 27/07/2023 | - | |
| Direttore Finanziario/CFO | 01/04/2021 | 03/04/2023 |
Storia della carriera di Clifford Saffron
Precedenti posizioni note di Clifford Saffron
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Animal Surgical Center of Michigan LLC | Amministratore Delegato | 01/03/2020 | 01/03/2021 |
Hoffman Technologies, Inc.
 Hoffman Technologies, Inc. Information Technology ServicesTechnology Services Hoffman Technologies, Inc. provides information technology services. It offers technology hardware, software, and services resale. The firm also offers technology products, technology services, office supplies, janitorial supplies, tactical supplies, industrial supplies, and various other consumer and consumable products. It also offers services to distributors, wholesalers, retailers and manufacturers. The company was founded by Gary C. Hoffman and Kevin Hoffman in 1997 and is headquartered in Rocklin, CA. | Presidente | 01/10/2018 | 01/03/2020 |
Yamo Pharmaceuticals LLC
 Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Yamo Pharmaceuticals LLC is a clinical stage pharmaceutical company that was founded in 2015. Yamo Pharmaceuticals is a privately held company and is based in New York, NY. The company's focus is on developing L1-79, a novel therapy that has the potential to improve the core symptoms of ASD. The CEO of the company is Charles J. Bramlage. | Corporate Officer/Principal | 01/10/2018 | 01/03/2020 |
| Kps Life Sciences | Corporate Officer/Principal | 01/10/2018 | 01/03/2020 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Consigliere Generale | 01/02/2002 | 01/02/2005 |
| ICN Pharmaceuticals, Inc. /Old/ | Corporate Officer/Principal | 01/01/1994 | 01/01/2001 |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| General Counsel | 2 |
| Chief Executive Officer | 2 |
Settori
| Health Technology | 4 |
| Technology Services | 2 |
| Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OPTIMUS HEALTHCARE SERVICES, INC. | Consumer Non-Durables |
| Aziende private | 6 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Hoffman Technologies, Inc.
Hoffman Technologies, Inc. Information Technology ServicesTechnology Services Hoffman Technologies, Inc. provides information technology services. It offers technology hardware, software, and services resale. The firm also offers technology products, technology services, office supplies, janitorial supplies, tactical supplies, industrial supplies, and various other consumer and consumable products. It also offers services to distributors, wholesalers, retailers and manufacturers. The company was founded by Gary C. Hoffman and Kevin Hoffman in 1997 and is headquartered in Rocklin, CA. | Technology Services |
| ICN Pharmaceuticals, Inc. /Old/ | Health Technology |
Yamo Pharmaceuticals LLC
Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Yamo Pharmaceuticals LLC is a clinical stage pharmaceutical company that was founded in 2015. Yamo Pharmaceuticals is a privately held company and is based in New York, NY. The company's focus is on developing L1-79, a novel therapy that has the potential to improve the core symptoms of ASD. The CEO of the company is Charles J. Bramlage. | Health Technology |
| Kps Life Sciences | |
| Animal Surgical Center of Michigan LLC |
- Borsa valori
- Insiders
- Clifford Saffron
- Esperienza
